Synthesis, spectral studies and screening for amoebicidal activity of new palladium(II) complexes derived from thiophene-2-carboxaldehyde thiosemicarbazones

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 4, 2003, Pages 689-692

  Shailendra, ^a   Bharti, Neelam ^a,b   Naqvi, Fehmida ^a   Azam, Amir ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DERIVATIVE; HYDRAZINE DERIVATIVE; METRONIDAZOLE; PALLADIUM COMPLEX; THIOPHENE 2 CARBOXALDEHYDE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; ENTAMOEBA HISTOLYTICA; IN VITRO STUDY; INFRARED RADIATION; NONHUMAN; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE;

AMEBICIDES; ANIMALS; DRUG EVALUATION, PRECLINICAL; ENTAMOEBA HISTOLYTICA; INHIBITORY CONCENTRATION 50; ORGANOMETALLIC COMPOUNDS; PALLADIUM; SPECTRUM ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; THIOSEMICARBAZONES;

ENTAMOEBA HISTOLYTICA;

EID: 0037294821     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)01005-3     Document Type: Article

References (30)

1. Walsh J.A. Rev. Infect. Dis. 8:1986;228.
2. Freeman C.D., Klutman N.E., Lamp K.C. Drugs. 54:1997;679.
3. Lamp K.C., Freeman C.D., Klutman N.E., Lacy M.K. Clin. Pharmacokinet. 36:1999;353.
4. Samarawickrema N.A., Brown D.M., Upcroft J.A., Thammapalerd N., Upcroft P. J. Antimicrob. Chemother. 40:1997;833.
5. Wassmann C., Helberg A., Tannich E., Bruchhaus I. J. Biol. Chem. 37:1999;26051.
6. Townson S.M., Boreham P.F.L., Upcroft P., Upcroft J.A. Acta Trop. 56:1994;173.
7. Domagk G., Behnisch R., Mietzsch F., Schmidt H. Naturwissenschaften. 33:1946;315.
8. Casero R.A., Klayman D.L., Childs G.E., Scovill J.P., Desjardins R.E. Antimicrob. Agents Chemother. 18:1980;317.
9. Klayman D.L., Bartosevich J.F., Griffin T.S., Mason C.J., Scovill J.P. J. Med. Chem. 22:1979;855.
10. Dimmock J.R., Pandeya S.N., Quil J.W., Pugazhenthi U., Allen T.M., Kao G.Y., Balzarine J., Declercq E. Eur. J. Med. Chem. 30:1995;655.
11. Easmon J., Purstinger G., Heinisch G., Roth T., Fiebig H.H., Holzer W., Jager W., Jenney M., Hofmann J. J. Med. Chem. 44:2001;2164.
12. Hall I.H., Wong O.T., Chapman J.M. Anticancer Drugs. 6:1995;147.
13. Johnson C.W., Joyner J.W., Perry R.P. Antimicrob. Chemother. 2:1952;636.
14. West D.X., Carlson C.S., Bouck K.J. Trans. Met. Chem. 16:1991;271.
15. Rosenberg, B. In Nucleic Acid-Metal Ion Interaction; Spiro, T. G. Ed.; Wiley: New York, 1980; p 1.
16. Farrell, N. Transition Metal Complexes as Drugs and Chemotherapeutic Agents. In Catalysis by Metal Complexes; James, B. R. Ugo, R. Eds.; Kluwer: Dordrecht, 1989.
17. Sun M. Science (Washington, DC). 222:1983;145.
18. West D.X., Liberta A.E. Coord. Chem. Rev. 123:1993;49.
19. Anderson F.E., Duca C.J., Scudi J.V. J. Am. Chem. Soc. 73:1951;4967.
20. Wiles D.M., Suprunchuk T. J. Med. Chem. 14:1971;252.
21. Garcia-Tojal J., Garcia-Orad A., Serra J.L., Pizarro J.L., Lezama L., Arriortua M.I., Rojo T. J. Inorg. Biochem. 75:1999;45.
22. Shailendra, Bharti N., Gonzalez Garza M.T., Cruz-Vega D.E., Garza J.C., Saleem K., Naqvi F., Azam A. Bioorg. Med. Chem. Lett. 11:2001;2675.
23. O'Sullivan D.G., Sadler P.W., Webley C. Chemotherapia. 7:1963;17.
24. Price J.H., Williamson A.N., Schramm R.F., Wayland B.B. Inorg. Chem. 116:1972;1280.
25. -1) 25,517, 35,998, 49,607.
26. Singh B., Mishra H. J. Ind. Chem. Soc. 63:1986;692.
27. Wright C.W., O'Neill M.J., Phillipson J.D., Warhurst D.C. Antimicrob. Agents Chemother. 32:1988;1725.
28. Cedeno J.R., Krogstad D.J. J. Infect. Dis. 148:1983;1090.
29. Klayman D.L., Bartosevich J.F., Griffin T.S., Mason C.J., Scovill J.P. J. Med. Chem. 22:1979;855.
30. Dobek A.S., Klayman D.L., Dickson J.R.E.T., Scvill J.P., Tramont E.C. Antimicrob. Agents Chemother. 28:1980;27.